Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/1997
07/01/1997US5643901 Medicament for treating idiopathic thrombocytopenic purpura
07/01/1997US5643900 Method for treatment of pathological conditions associated with angiogenesis and preparation therefor
07/01/1997US5643899 Lipids for epidermal moisturization and repair of barrier function
07/01/1997US5643898 Combination of derivatives of pyrimidine and of hydrocortisone for inducing and stimulating the growth of hair and reducing its loss
07/01/1997US5643897 Amitriptyline, trimipramine, trazodone
07/01/1997US5643896 2-Benzyl-3-arylbenzothiophenes
07/01/1997US5643895 Phosphonoacetic esters and acids as anti-inflammatories
07/01/1997US5643893 Antiinflammatory agents or antiarthritic agents
07/01/1997US5643892 Administering pentosan polysulfate, arresting the disease and dissolving already formed scars and fibrotic lesions
07/01/1997US5643888 Regulating retroviral replication, infection, and pathogenesis
07/01/1997US5643886 Avermectins and milbemycins to treat parasitic infestations in dogs
07/01/1997US5643885 Etoposide derivatives, process for preparing them, their use as a medicinal product and their use for the preparation of a medicinal product intended for anti-cancer treatment
07/01/1997US5643884 Antiinflammatory agents
07/01/1997US5643883 Glucose-6-phosphate uptake inhibitors and novel uses thereof
07/01/1997US5643879 Oligopeptide enzyme inhibitors as hypotensive agents
07/01/1997US5643874 Pharmaceutical composition comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor
07/01/1997US5643788 Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides
07/01/1997US5643778 RNA editing enzyme and methods of use thereof
07/01/1997US5643748 HU-B1.219, a novel human hematopoietin receptor
07/01/1997US5643623 Health food product and its uses
07/01/1997US5643608 Low pH germicidal iodine compositions having enhanced stability
07/01/1997US5643602 Oral composition for the treatment of inflammatory bowel disease
07/01/1997US5643598 Method of skin care utilizing liposomes containing Scutellaria extracts
07/01/1997US5643597 Use of a tocopherol phosphate or one of its derivatives for the preparation of cosmetic or pharmaceutical compositions and compositions so obtained
07/01/1997US5643586 Skin disorders and antiaging agents
07/01/1997US5643584 Aqueous gel retinoid dosage form
07/01/1997US5643583 Cosmetic or pharmaceutical composition for topical use
07/01/1997US5643575 Non-antigenic branched polymer conjugates
07/01/1997US5643562 Method for treating amyloidosis
07/01/1997US5642728 System for dispensing pharmaceutically active compounds
07/01/1997CA2134359C New n-aryl and n-heteroarylurea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat)
07/01/1997CA2128248C Amino acids useful as inhibitors of the advanced glycosylation of proteins
07/01/1997CA2043003C Infant formula
07/01/1997CA2027133C Inclusion complexes with silybinin, their preparation and pharmaceutical compositions containing them
07/01/1997CA2012381C Reduced calorie fat compositions containing polyol polyesters and reduced calorie triglycerides
06/1997
06/29/1997CA2188247A1 Soluble concentrated frozen/refrigerated calcium preparation comprising calcium citrate-malate and process for producing the same
06/28/1997CA2193781A1 Contact lens containing a leachable absorbed material
06/28/1997CA2166154A1 Binding agents and the use thereof
06/26/1997WO1997022880A1 Use of rc-9 in diagnosis and treatment of proliferative arterial disease
06/26/1997WO1997022702A1 Diagnosis and treatment of aur-1 and/or aur-2 related disorders
06/26/1997WO1997022699A2 Murine monoclonal anti-idiotype antibody 11d10 an methods of use thereof
06/26/1997WO1997022697A1 TGFβ SIGNAL TRANSDUCTION PROTEINS, GENES, AND USES RELATED THERETO
06/26/1997WO1997022696A1 Utrophin gene expression
06/26/1997WO1997022695A2 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer
06/26/1997WO1997022628A1 Intravascular membrane thickening inhibitor
06/26/1997WO1997022624A2 Cosmetic preparations containing vertebrate proteins and having antibacterial, antimycotical and antiviral action
06/26/1997WO1997022623A1 Osteo antiviral protein
06/26/1997WO1997022621A2 Antineoplastic peptides
06/26/1997WO1997022620A1 Oligopeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone
06/26/1997WO1997022619A2 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
06/26/1997WO1997022613A1 Phospholipid derivatives of phosphono-carboxylic acids, the production of said derivatives and the use of said derivatives as antiviral medicaments
06/26/1997WO1997022609A1 4-substituted cephem derivatives as elastase inhibitors
06/26/1997WO1997022606A1 Morphine derivatives with analgesic activity
06/26/1997WO1997022604A1 Novel substituted 4-(1h-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
06/26/1997WO1997022603A1 Method for the synthesis of a benzimidazole compound
06/26/1997WO1997022600A1 N-substituted dioxothiazolidylbenzamide derivatives and process for producing the same
06/26/1997WO1997022597A1 Piperazine derivatives as tachykinin antagonists
06/26/1997WO1997022596A1 Quinazoline derivatives
06/26/1997WO1997022595A1 Arylethenesulfonamide derivatives and drug composition containing the same
06/26/1997WO1997022589A1 Benzamide derivatives as thrombin inhibitors
06/26/1997WO1997022588A1 Use of hetarylacetic acid derivatives as leukotriene inhibitors
06/26/1997WO1997022587A1 Alpha-substituted arylsulphonamido hydroxamic acids as tnf-alpha and matrix metalloproteinase inhibitors
06/26/1997WO1997022586A1 Tri-aryl ethane derivatives as pde iv inhibitors
06/26/1997WO1997022372A1 Use of injectable or implantable biomaterials for filling or blocking lumens and voids of the body
06/26/1997WO1997022368A2 Covalent lipid-phosphono-carboxylic acid conjugates and application thereof as antiviral medicaments
06/26/1997WO1997022362A1 Agent for prevention and depression of dry coughing caused by angiotensin converting enzyme inhibitors
06/26/1997WO1997022360A2 Control of protein synthesis, and screening method for agents
06/26/1997WO1997022359A1 Combination of g-csf with a chemotherapeutic agent for stem cell mobilisation
06/26/1997WO1997022354A2 Use of a medicament and use of mixture of substances to produce a medicament
06/26/1997WO1997022347A1 Potentiation of complement and coagulation inhibitory properties of c1-inhibitor.
06/26/1997WO1997022346A2 Use of sugar derivatives as antimicrobial, antimycotic and/or antiviral active substances
06/26/1997WO1997022345A1 Phospholipid and propylene glycol based lubricant
06/26/1997WO1997022344A1 Process for production of piperidine derivatives
06/26/1997WO1997022343A1 USE OF α,α-DIPHENYLACETIC ACID-4-(N-METHYL-PIPERIDYL)ESTER AS ANTI-SPASMODIC
06/26/1997WO1997022342A1 Novel method
06/26/1997WO1997022341A1 Endothelin receptor antagonists
06/26/1997WO1997022340A1 Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof
06/26/1997WO1997022339A1 Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
06/26/1997WO1997022338A1 Novel method
06/26/1997WO1997022335A1 A controlled release formulation for poorly soluble basic drugs
06/26/1997WO1997022334A1 Pge-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
06/26/1997WO1997022333A1 Archaeosomes, archaeosomes containing coenzyme q10, and other types of liposomes containing coenzyme q10 as adjuvants and as delivery vehicles
06/26/1997WO1997022251A1 Compositions for modulating intracellular inositol trisphosphate concentration and uses thereof
06/26/1997WO1997022250A1 Therapeutic molecules generated by trans-splicing
06/26/1997WO1997022248A1 Composition for organ cryopreservation and treatment of viral and bacterial infections
06/26/1997WO1997019703A3 Thyroxine/cyclodextrin complexes and pharmaceutical compositions containing the same
06/26/1997WO1997018816A3 Sulfate conjugates of ursodeoxycholic acid, and their beneficial use in inflammatory disorders and other applications
06/26/1997WO1997013845A3 Phosphopantetheinyl transferases and uses thereof
06/26/1997WO1997011190A3 Dna construct comprising a muscle specific regulatory element for immunization or gene therapy
06/26/1997WO1997010005A3 Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response
06/26/1997DE19608753C1 Transduction system based on rep-negative adeno-associated virus vector
06/26/1997DE19549264A1 Verfahren und Kit zur Kontrazeption Method and kit for contraception
06/26/1997DE19549243A1 Pharmazeutische Präparate enthaltend Clathrate von Cyclodextrinen und nichtnatürliche Vitamin D-Analoga A pharmaceutical composition comprising clathrates of cyclodextrins and non-natural vitamin D analogues
06/26/1997DE19549232A1 Verwendung von G-CSF in Kombination mit einem Chemotherapeutikum zur Herstellung eines pharmazeutischen Präparates zur verstärkten Mobilisierung hämatopoetischer Stammzellen Use of G-CSF in combination with a chemotherapeutic agent for the preparation of a pharmaceutical composition for enhanced mobilization of hematopoietic stem cells
06/26/1997DE19548708A1 Cyclische Sulfone Cyclic sulfones
06/26/1997DE19548624A1 Neue Barbitursäure-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel New barbituric acid derivatives, processes for their preparation and medicaments containing these compounds
06/26/1997DE19548122A1 Nukleinsäuresequenzen von Genen der High Mobility Group Proteine sowie Verwendungen derselben Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
06/26/1997DE19548114A1 Konjugat, umfassend einen Wirkstoff, ein Polypeptid und einen Polyether A conjugate comprising an active substance, a polypeptide and a polyether
06/26/1997CA2244396A1 Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof
06/26/1997CA2241080A1 Control of protein synthesis, and screening method for agents